CNE100001KV8
CNE100001KV8
TIGERMED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 47.51B EUR | 41.33B EUR | 46.35B EUR |
Enterprise Value | 53.71B EUR | 41.57B EUR | 45.9B EUR |
Valuation Multiples | |||
Trailing P/E | 501.64x | -- | 154.58x |
Forward P/E | 44.86x | -- | -- |
Price to Sales | 6.52x | 5.74x | 6.76x |
Price to Book | 2.56x | 2.12x | 2.22x |
EV/Revenue | 7.37x | 5.77x | 6.69x |
EV/EBITDA | 62.03x | 25.68x | 31.97x |
Price to FCF (P/FCF) | 50.07x | 50.69x | 50.78x |
EV/FCF | 56.59x | 50.99x | 50.29x |
FCF Yield | 2% | 1.97% | 1.97% |